2000/358/EC: Commission Decision of 24 May 2000 extending the possible time period for provisional authorisations of the new active substances flupyrsulfuron methyl, carfentrazone ethyl, prosulfuron, flurtamone, isoxaflutole (notified under document number C(2000) 1376) (Text with EEA relevance)
Date: 2000-05-24
Institutions: European Commission
Subjects: EU Member State, dangerous substance, marketing, pharmaceutical product, plant health product

27.5.2000

EN

Official Journal of the European Communities

L 127/61

COMMISSION DECISION

of 24 May 2000

extending the possible time period for provisional authorisations of the new active substances
flupyrsulfuron methyl, carfentrazone ethyl, prosulfuron, flurtamone, isoxaflutole

(notified under document number C(2000) 1376)

(Text with EEA relevance)

(2000/358/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(4)

Having regard to the Treaty establishing the European
Community,

Having regard to Council Directive 91/414/EEC of 15 July
1991 concerning the placing of plant protection products on
the market (1), as last amended by Commission Directive 1999/
80/EC of 28 July 1999 (2), and in particular Article 8(1) fourth
subparagraph thereof,

Whereas:

(1)

(2)

(3)

91/414/EEC (hereinafter

Directive
‘the Directive’)
provided for the development of a Community list of
active substances authorised for incorporation in plant
protection products.

Du Pont de Nemours submitted a dossier for the new
active substance flupyrsulfuron methyl to France on 26
October 1995 with a view to obtaining the inclusion of
the active substance in Annex I to the Directive. The
effects on human health and the environment are being
assessed,
in accordance with the provisions of Article
6(2) and (4) of the Directive, for the uses proposed by
the applicant. France acting as nominated rapporteur
Member State, submitted to the Commission on 2
December 1997 the draft assessment report concerned.
The submitted report is being reviewed by the Member
States and the Commission within the framework of the
Standing Committee on Plant Health and in working
groups thereof. Additional time is required to complete
the full examination of
the scientific and technical
dossier.

FMC Europe NV submitted a dossier for the new active
substance carfentrazone ethyl to France on 14 February
1996 with a view to obtaining the inclusion of the
active substance in Annex I to the Directive. The effects
on human health and the environment are being
assessed,
in accordance with the provisions of Article
6(2) and (4) of the Directive, for the uses proposed by
the applicant. France acting as nominated rapporteur
Member State, submitted to the Commission on 14 May
1998 the draft assessment
report concerned. The
submitted report is being reviewed by the Member States
and the Commission within the framework of
the
Standing Committee on Plant Health and in working
groups thereof additional time is required to complete
the full examination of
the scientific and technical
dossier.

(1) OJ L 230, 19.8.1991, p. 1.
(2) OJ L 210, 10.8.1999, p. 13.

for

submitted a dossier

Novartis
the new active
substance prosulfuron to France on 14 May 1995 with a
view to obtaining the inclusion of the active substance
in Annex I to the Directive. The effects on human health
and the environment are being assessed, in accordance
with the provisions of Article 6(2) and (4) of
the
Directive, for the uses proposed by the applicant. France
acting
State,
submitted to the Commission on 18 January 1999 the
draft assessment report concerned. The submitted report
is being reviewed by the Member States and the
Commission within the framework of
the Standing
Committee on Plant Health and in working groups
thereof. Additional time is required to complete the full
examination of the scientific and technical dossier.

rapporteur Member

nominated

as

(5)

(6)

Rhone-Poulenc Agro France submitted a dossier for the
new active substance flurtamone to France on 15
February 1994 with a view to obtaining the inclusion of
the active substance in Annex I to the Directive. The
effects on human health and the environment are being
assessed,
in accordance with the provisions of Article
6(2) and (4) of the Directive, for the uses proposed by
the applicant. France acting as nominated rapporteur
Member State, submitted to the Commission on 16 May
1997 the draft assessment
report concerned. The
submitted report is being reviewed by the Member States
and the Commission within the framework of
the
Standing Committee on Plant Health and in working
groups thereof. Additional time is required to complete
the full examination of
the scientific and technical
dossier.

Rhone-Poulenc Agro France submitted a dossier for the
new active substance isoxaflutole to the Netherlands on
6 March 1996 with a view to obtaining the inclusion of
the active substance in Annex I to the Directive. The
effects on human health and the environment are being
in accordance with the provisions of Article
assessed,
6(2) and (4) of the Directive, for the uses proposed by
the applicant. The Netherlands acting as nominated
rapporteur Member State, submitted to the Commission
on 20 February 1997 the draft assessment
report
concerned. The submitted report is being reviewed by
the Member States and the Commission within the
framework of the Standing Committee on Plant Health
time is
and in working groups thereof. Additional
the
required to complete the full examination of
scientific and technical dossier.

(7)

The measures provided for in this Decision are in
accordance with the opinion of the Standing Committee
on Plant Health,

L 127/62

EN

Official Journal of the European Communities

27.5.2000

HAS ADOPTED THIS DECISION:

Article 2

Article 1

Done at Brussels, 24 May 2000.

This present Decision is addressed to the Member States.

Member States may extend provisional authorisations already
granted for plant protection products containing flupyrsulfuron
methyl, carfentrazone ethyl, prosulfuron, flurtamone and isoxa-
flutole for a period not exceeding 12 months from the date of
adoption of this Decision.

For the Commission

David BYRNE

Member of the Commission